Objective
DNA interstrand crosslinks (ICLs) are toxic lesions, which prevent the separation of strands necessary for DNA replication. ICLs arise in cells when common endogenous metabolites react with DNA and when cells are exposed to commonly used chemotherapeutic drugs, such as mitomycin-C (MMC) and cisplatin. Defects in the repair of endogenous ICLs cause Fanconi anaemia, characterized by chromosome instability and cancer predisposition, which underscores the importance of ICL repair for human health. In 2010, several groups reported the identification of Fan1, a structure-specific nuclease that is required for ICL repair, but the underlying mechanisms are unclear and little is known about how Fan1 promotes DNA repair. Recently, it was reported that Fan1 mutations in humans cause karyomegalic interstitial nephritis (KIN), which is characterized by degeneration of organs including kidney. This may reflect premature aging of organs caused by unrepaired DNA damage. The lab in which I will carry out the proposed studies is generating Fan1K975A/K975A knock-in mice, which express a nuclease-inactive form of Fan1. I will study these mice in detail to test the consequences of Fan1 inactivation at the level of cell and organism. I am particularly interested in testing for a Fanconi anaemia-like phenotype and/or progeria. Cells from the Fan1-defective mice will be used to determine the role of Fan1 in ICL repair. There are several nucleases other than Fan1 required for ICL repair, such as Mus81-Eme1 and Slx1. I will also test the relationship between Fan1 these factors by making mouse defective in Fan1 and each of these factors. Finally I aim to study the regulation of Fan1 function by phosphorylation. These experiments will provide valuable insight into Fan1 function, and the project will give me the opportunity to change discipline and to work in the one of the best scientific environments in the UK that has strong connections with Europe and with industry.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences genetics DNA
- natural sciences biological sciences genetics mutation
- medical and health sciences clinical medicine oncology
- natural sciences biological sciences genetics chromosomes
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2012-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
DD1 4HN Dundee
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.